Get to grips with the new insurance rules

Imagine you are a general counsel or director in whose department sits the person who buys your company’s insurance policies. You may be about to become a star witness in insurance disputes. Is that news to you? Are you concerned by it?

Premium content

This article is only available to Premium subscribers of The Lawyer. Premium subscribers benefit from accessing all of our award-winning online content including interviews, commentary, analysis and in-depth research.

View our subscription options

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here 

Latest Briefings

FCA opens notifications for temporary permissions regime in case of no-deal Brexit

By François Pfister, Anne-Gaëlle Delabye In order to ensure that investment funds that are currently marketed in the United Kingdom under the European Economic Area (EEA) passporting regime continue to be able to do so in the event of there being no implementation period based on the withdrawal agreement after 29 March (no-deal Brexit), the […]

Changes in the procedure for admission of foreign medical devices and medicines to public procurement in Russia

On 1 January 2019, amendments to the Resolution of the Government of the Russian Federation No. 102 of 05.02.2015 that provides for restrictions and conditions for the admission of certain types of medical devices originating from foreign countries for the purpose of procurement for state and municipal needs (“Resolution No. 102”). And the Resolution of […]

Recommended

Star legal writers: intellectual property

IP rows involving rock band Radiohead, Lego and the Happy Birthday tune, and charity domain name developments are just some of the subjects discussed by our expert briefings writers.

Gowling WLG advises argenx on $625m collaboration to develop cancer treatment

Gowling WLG’s Life Sciences team has advised argenx on its collaboration with global biopharmaceutical company AbbVie to develop ARGX-115, a potential treatment for cancer. Patrick Duxbury, head of life sciences, worked with associate Elwin Morgan on the collaboration agreement. Patrick worked closely with senior VP of business development at argenx, Dr Debbie Allen and with CEO Tim van Hauwermeiren. […]

Recruit legal talent

Get your role in front of over 300,000 legal professionals when you advertise with The Lawyer. Our team of experts provide bespoke solutions to help solve all your recruitment challenges.

Find out more

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here